We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Akers Bio | LSE:AKR | London | Ordinary Share | COM SHS NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 57.50 | 50.00 | 65.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/12/2015 09:16 | might be worth a punt at 30p | deanroberthunt | |
22/12/2015 09:16 | all these years and revenue still less than my local brothel.... | deanroberthunt | |
22/12/2015 00:05 | Still testing a chart low it seems buywell3 15 Nov'15 - 22:34 - 3012 of 3026 0 0 edit whoops Down it goes .. to an all time low ? | buywell3 | |
18/12/2015 16:51 | There appears no end to the misery the share price or Dr Akers can cause us. I assumed the worst was over. Appears I was wrong. | algernon2 | |
18/12/2015 15:25 | SP 95? On its way to becoming a penny share ... again | werewolfie | |
26/11/2015 21:40 | SA ? South Africa or Sanofi Aventis? | algernon2 | |
26/11/2015 16:19 | a carton? that's what they used in SA when HIV was consuming large numbers | norbus | |
25/11/2015 10:24 | Lets hope its not the final "curton" as Norbus thinks or even the final "curtain". Onwards and upwards. | algernon2 | |
25/11/2015 08:23 | Hope he becomes John the Great and not John the Gormless | werewolfie | |
25/11/2015 06:32 | mcm wherefore art thou, oh deserter; do you agree the ceo is there to pull the final curton? | norbus | |
23/11/2015 22:58 | Akers has hired the man for his exit plan | norbus | |
23/11/2015 07:27 | A CEO, since T Nicolette , is about time; That he does not sit on the board is gross ?!! whoaa | norbus | |
17/11/2015 08:14 | Bad enough to lose, but to suffer like this is cruel; the adjusted high was 21000 to today's 140 ; a fractionation to 1/ 150 th of the high; | norbus | |
16/11/2015 22:06 | Akers Biosciences (AKER) Q3 Loss Widens Y/Y, Shares Tank Zacks | algernon2 | |
15/11/2015 22:44 | Yes indeed not great but stuff it in my Isa and get a nice capital gains loss for when it or something else hopefully comes good. New website is definite improvement and there's even a nice photo of Raymond and the others on it. Enjoy! Good luck to all us poor benighted fools here. also a new interview with Raymond re the results: | algernon2 | |
15/11/2015 22:34 | whoops Down it goes .. to an all time low ? | buywell3 | |
15/11/2015 22:16 | The website has changed quite dramatically: (about bloody time). Check it out: | algernon2 | |
13/11/2015 16:23 | Jeez - sorry guys. How sustainable is this? | werewolfie | |
13/11/2015 08:01 | mcm Did you see results like these Q3 ever? $2.2 loss off 169k revenue and $5m on B/S not sure if all realisable It is a disgrace how this company has always been run; I suppose if HSBC can launder $400bn for terror and drugs , open tax avoidance Swiss bank accounts and get away unscathed, then Akers has no reason to fear being held accountable. Shame on the Nomad; Pity the fund manager who bought 6% pre NASDAQ : there but for the Grace of G-d go I Lucky to hold above £1 today; It has bust all over it | norbus | |
13/11/2015 07:59 | Results look terrible - Not sure if already factored into share price - Management making best of massive cah burn but (reading between the lines could be setting up for another cash raise) imo. Declaration I used to hold but sold out for a loss but loss would hae been even bigger now. Guesses as to how much further it will fall today ? | pugugly | |
13/11/2015 07:57 | That looks like a profit (loss)warning. It's still jam tomorrow. | this_is_me | |
04/11/2015 09:46 | Great news today - the Chinese FDA have approved "for medical use throughout Mainland China the Company's flagship rapid tests for allergic reactions associated with the widely used blood-thinner, heparin." With Novotek already in place as the distributor, this is excellent news for a mere £9.7m m/cap company. And Akers' test is the "first and only" such test of its kind in China. Consider the size of Novotek: "NovoTek Therapeutics Inc. is a vital part of NovoTek Group, and is in charge of all international business. To date, NovoTek Group has grown to seven subsidiary companies focused on pharmaceutical marketing, medical and IVD products marketing, and contract research services. NovoTek has its own preclinical research facility, clinical trial and regulatory teams, and more than 600 sales representatives (500 for pharmaceuticals and 100 for medical devices) across China. NovoTek has more than 800 employees and more than 10 local branches nationwide. www.novotekchina.com " | rivaldo | |
19/10/2015 09:45 | Very important test by what the article describes and might have transformed AKR ; Could it be Abbott is selling on behalf of AKR who were the inventors ? | norbus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions